Erik Harris, Chief Officer of Ultragenyx Pharmaceutical RARE, has filed 0 purchases and 6 sales on the open market. Over the past 12 months that comes to a net sale of $240.3K. The latest trade was on 04/16.

EH

EH

Erik Harris

EVP & Chief Commercial Officer

Company

Ultragenyx Pharmaceutical RARE

First filing

23/03/03

Trades

26 trades

Buys / sales

0 / 6

12-month net buying

−$240.3K

Last trade

04/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Ultragenyx PharmaceuticalRARE	Open-market sale	03/02	03/03	10,539 sh	$22.80	$240,289.2	−10.5%
Ultragenyx PharmaceuticalRARE	Open-market sale	25/03/03	25/03/04	15,103 sh	$42.10	$635,836.3	−14.7%
Ultragenyx PharmaceuticalRARE	Open-market sale	24/03/01	24/03/05	4,768 sh	$53.76	$256,327.68	−6.6%
Ultragenyx PharmaceuticalRARE	Open-market sale	23/09/05	23/09/06	6,000 sh	$37.96	$227,760	−10.5%
Ultragenyx PharmaceuticalRARE	Open-market sale	23/06/19	23/06/21	305 sh	$48.20	$14,701	−0.5%
Ultragenyx PharmaceuticalRARE	Open-market sale	23/03/01	23/03/03	3,664 sh	$45.25	$165,796	−6.0%